Nonclassical Zwitterions as a Design Principle to Reduce Lipophilicity without Impacting Permeability.
Möbitz H, Dittrich B, Rodde S, Strang R.
J Med Chem · research-article; journal article · DOI 10.1021/acs.jmedchem.4c00596 PUBLIKATIONSREGISTRET
Gå till forskningen.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för sudoxicam. Visa hela publikationsregistret
En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publikationer i urvalet
8 träffarDesigning around Structural Alerts in Drug Discovery.
Kalgutkar AS.
J Med Chem · research support, non-u.s. gov't; journal article · DOI 10.1021/acs.jmedchem.9b00917A predictive ligand-based Bayesian model for human drug-induced liver injury.
Ekins S, Williams AJ, Xu JJ.
Drug Metab Dispos · journal article · DOI 10.1124/dmd.110.035113Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Guerra A, Campillo NE, Páez JA.
Eur J Med Chem · research support, non-u.s. gov't; journal article · DOI 10.1016/j.ejmech.2009.11.034Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
Jolivette LJ, Ward KW.
J Pharm Sci · comparative study; journal article · DOI 10.1002/jps.20373Comparative evaluation of oral systemic exposure of 56 xenobiotics in rat, dog, monkey and human.
Ward KW, Nagilla R, Jolivette LJ.
Xenobiotica · comparative study; journal article · DOI 10.1080/00498250400028197Effect of structural modification of enol-carboxamide-type nonsteroidal antiinflammatory drugs on COX-2/COX-1 selectivity.
Lazer ES, Miao CK, Cywin CL, Sorcek R, Wong HC, Meng Z, Potocki I, Hoermann M, Snow RJ, Tschantz MA, Kelly TA, McNeil DW, Coutts SJ, Churchill L, Graham AG, David E, Grob PM, Engel W, Meier H, Trummlitz G.
J Med Chem · journal article · DOI 10.1021/jm9607010Novel, potent aldose reductase inhibitors: 3,4-dihydro-4-oxo-3-[[5-(trifluoromethyl)-2-benzothiazolyl] methyl]-1-phthalazineacetic acid (zopolrestat) and congeners.
Mylari BL, Larson ER, Beyer TA, Zembrowski WJ, Aldinger CE, Dee MF, Siegel TW, Singleton DH.
J Med Chem · comparative study; journal article · DOI 10.1021/jm00105a018